{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:35:20Z","timestamp":1787726120408,"version":"build-2784847793"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>This cohort study uses target trial emulation to explore the comparative effectiveness of buprenorphine-naloxone and methadone for opioid overdose among youths in Canada.<\/jats:p>","DOI":"10.1001\/jamapediatrics.2026.0041","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:00:30Z","timestamp":1773068430000},"page":"577","source":"Crossref","is-referenced-by-count":3,"title":["Comparative Effectiveness of Buprenorphine-Naloxone and Methadone for Opioid Overdose Among Youths"],"prefix":"10.1001","volume":"180","author":[{"given":"Robert A.","family":"Kleinman","sequence":"first","affiliation":[{"name":"Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Larney","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Emergency Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheemot Olaoluwa","family":"Sule","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Ma","sequence":"additional","affiliation":[{"name":"Biostatistics, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Szatmari","sequence":"additional","affiliation":[{"name":"Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kurdyak","sequence":"additional","affiliation":[{"name":"Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"36","key":"pld260003r1","doi-asserted-by":"publisher","first-page":"E1195","DOI":"10.1503\/cmaj.251682","article-title":"Canada\u2019s youth are part of the opioid crisis and need treatment.","volume":"197","author":"Charlebois","year":"2025","journal-title":"CMAJ"},{"issue":"8","key":"pld260003r3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"pld260003r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100240","article-title":"Fentanyl, carfentanil and other fentanyl analogues in Canada\u2019s illicit opioid supply: a cross-sectional study.","volume":"12","author":"Kleinman","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"issue":"7","key":"pld260003r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.18389","article-title":"Duration of methadone and buprenorphine-naloxone treatment.","volume":"8","author":"Kleinman","year":"2025","journal-title":"JAMA Netw Open"},{"key":"pld260003r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.111032","article-title":"Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: a population-based cohort study in Ontario, Canada.","volume":"254","author":"Iacono","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"pld260003r2","volume-title":"ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update","author":"American Society of Addiction Medicine","year":"2020"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2845520\/jamapediatrics_kleinman_2026_ld_260003_1777584372.56403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:01:08Z","timestamp":1777906868000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2845520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.0041","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}